SCHEMBL25906609

SCHEMBL25906609

CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)c1ccccc1C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.66
TSHR P16473 5/20 0.66
LMNA P02545 2/20 0.66
CYP3A4 P08684 2/20 0.63
MAPK1 P28482 2/20 0.63
TP53 P04637 1/20 0.63
L3MBTL1 Q9Y468 3/20 0.60
TDP1 Q9NUW8 2/20 0.60
DGKA P23743 1/20 0.58
KDM4E B2RXH2 3/20 0.55
HSD17B10 Q99714 2/20 0.55
POLB P06746 1/20 0.55
MEN1 O00255 1/20 0.52
RECQL P46063 1/20 0.52
KMT2A Q03164 1/20 0.52
PTPN11 Q06124 1/20 0.49
PRSS1 P07477 1/20 0.49
PRSS2 P07478 1/20 0.49
PRSS3 P35030 1/20 0.49
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9298568 0.90 ALDH1A1 (0.82) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL1943177 0.90 ALDH1A1 (0.82) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL28878375 0.90 ALDH1A1 (0.82) ALDH1A1TSHRLMNACYP3A4MAPK1
Phthalic Acid SCHEMBL23930308 0.90 TSHR (0.62) ALDH1A1TSHRLMNACYP3A4MAPK1
Phthalic Acid SCHEMBL29044821 0.90 TSHR (0.62) ALDH1A1TSHRLMNACYP3A4MAPK1
Phthalic Acid SCHEMBL28475412 0.90 TSHR (0.62) ALDH1A1TSHRLMNACYP3A4MAPK1
Phthalic Acid SCHEMBL29044822 0.90 TSHR (0.62) ALDH1A1TSHRLMNACYP3A4MAPK1
Phthalic Acid SCHEMBL28759173 0.90 TSHR (0.62) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL29023403 0.89 TSHR (0.66) ALDH1A1TSHRLMNACYP3A4MAPK1
Dibutyl Phthalate SCHEMBL10731020 0.89 ALDH1A1 (0.79) ALDH1A1TSHRLMNACYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235321-A1 GENE EDITING TO IMPROVE JOINT FUNCTION ORTHOBIO THERAPEUTICS INC (US) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235321-A1 GENE EDITING TO IMPROVE JOINT FUNCTION SYVN1, COL2A1, UTRN ALDH1A1 1559/4885TSHR 4498/4885LMNA 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.